Sunrise Medical Plans Listing on the Frankfurt Stock Exchange

Global leader in assistive mobility solutions, Sunrise Medical, intends to list on the regulated market of the Frankfurt Stock Exchange. The listing is slated for summer 2024, subject to market conditions. This move aims to bolster future growth and widen financing avenues.

The offering comprises newly issued shares and a secondary component from a Nordic Capital CV1 Limited-controlled shareholder. Sunrise Medical seeks to raise €240 million to repay existing debt, thus strengthening its balance sheet. The company achieved a 12% revenue increase in the first nine months of 2023/24, reaching €516 million.

Well-positioned in the growing rehabilitation market, Sunrise Medical offers a range of personalized and standard mobility products. With operations in 23 countries, its products are sold in over 130 countries. The complex rehabilitation market shows strong growth potential driven by global trends like increased life expectancy and rising chronic conditions.